|
1
|
Rueda-Clausen CF, Padwal RS and Sharma AM:
New pharmacological approaches for obesity management. Nat Rev
Endocrinol. 9:467–478. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fenske W, Athanasiou T, Harling L,
Drechsler C, Darzi A and Ashafian H: Obesity-related cardiorenal
disease: the benefits of bariatric surgery. Nat Rev Nephol.
9:539–551. 2013. View Article : Google Scholar
|
|
3
|
Tao W and Lagergren J: Clinical management
of obese patients with cancer. Nat Rev Clin Oncol. 10:519–533.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rosen ED and MacDougald OA: Adipocyte
differentiation from the inside out. Nat Rev Mol Cell Biol.
7:885–896. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kawai M and Rosen CJ: PPARy: A circadian
transcription factor in adipogenesis and osteogenesis. Nat Rev
Endocrinol. 6:629–636. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cristancho AG and Lazar MA: Forming
functional fat: a growing understanding of adipocyte
differentiation. Nat Rev Mol Cell Biol. 12:722–734. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Oishi Y, Manabe I, Tobe K, et al:
Kruppel-like transcription factor klf5 is a key regulator of
adipocyte differentiation. Cell Metab. 1:27–39. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Birsoy K, Chen Z and Friedman J:
Transcriptional regulation of adipogenesis by klf4. Cell Metab.
7:339–347. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Choi JH, Banks AS, Estall JL, et al:
Anti-diabetic drugs inhibit obesity-linked phosphorylation of
PPARgamma by cdk5. Nature. 466:451–456. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qiang L, Wang L, Kon N, et al: Brown
remodeling of white adipose tissue by sirt1-dependent deacetylation
of ppargamma. Cell. 150:620–632. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dutchak PA, Katafuchi T, Bookout AL, et
al: Fibroblast growth factor-21 regulates PPARgamma activity and
the antidiabetic actions of thiazolidinediones. Cell. 148:556–567.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zuniga E, Rippen M, Alexander C, Schilling
TF and Crump JG: Gremlin 2 regulates distinct roles of bmp and
endothelin 1 signaling in dorsoventral patterning of the facial
skeleton. Development. 138:5147–5156. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Suzuki D, Yamada A, Aizawa R, et al: bmp2
differentially regulates the expression of gremlin1 and gremlin2,
the negative regulators of bmp function, during osteoblast
differentiation. Calcif Tissue Int. 91:88–96. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Muller II, Melville DB, Tanwar V, et al:
Functional modeling in zebrafish demonstrates that the
atrial-fibrillation-associated gene GREM2 regulates cardiac
laterality, cardiomyocyte differentiation and atrial rhythm. Dis
Models Mech. 6:332–341. 2013. View Article : Google Scholar
|
|
15
|
Paternoster L, Lorentzon M, Lehtimaki T,
et al: Genetic determinants of trabecular and cortical volumetric
bone mineral densities and bone microstructure. PLoS Genet.
9:e10032472013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Macotela Y, Emanuelli B, Mori MA, et al:
Intrinsic differences in adipocyte precursor cells from different
white fat depots. Diabetes. 61:1691–1699. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Takahashi A, Morita M, Yokoyama K, Suzuki
T and Yamamoto T: Tob2 inhibits peroxisome proliferator-activated
receptor gamma2 expression by sequestering smads and c/ebpalpha
during adipocyte differentiation. Mol Cell Biol. 32:5067–5077.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ross SE, Hemati N, Longo KA, et al:
Inhibition of adipogenesis by wnt signaling. Science. 289:950–953.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Laudes M: Role of WNT signalling in the
determination of human mesenchymal stem cells into preadipocytes. J
Mol Endocrinol. 46:R65–R72. 2011.PubMed/NCBI
|
|
20
|
Prestwich TC and Macdougald OA:
Wnt/beta-catenin signaling in adipogenesis and metabolism. Curr
Opin Cell Biol. 19:612–617. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wright WS, Longo KA, Dolinsky VW, et al:
WNT10b inhibits obesity in ob/ob and agouti mice. Diabetes.
56:295–303. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chistodoulides C, Scarda A, Granzotto M,
et al: WNT10B mutations in human obesity. Diabetologia. 49:678–684.
2006. View Article : Google Scholar
|
|
23
|
Takada I, Kouzmenko AP and Kato S: Wnt and
PPARgamma signaling in osteoblastogenesis and adipogenesis. Nat Rev
Rheumatol. 5:442–447. 2009. View Article : Google Scholar : PubMed/NCBI
|
